AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
74 hedge funds and large institutions have $18.6M invested in Accelerate Diagnostics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 25 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
96% less call options, than puts
Call options by funds: $34K | Put options by funds: $842K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
74
Holding in Top 10
–
Calls
$34K
Puts
$842K
Top Buyers
| 1 | +$2.46M | |
| 2 | +$1.16M | |
| 3 | +$977K | |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
+$252K |
| 5 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$159K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$1.71M | |
| 3 | -$1.32M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$979K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$613K |